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Multiwalled carbon nanotubes have been shown to possess unusual fibrogenic activity in vivo and are currently the focus of intense
toxicological investigations. This study further determines the fibrogenic potential of well-dispersed MWCNT in human lung cell
culture models and to develop a novel platform for understanding the cellular mechanisms of MWCNT-induced lung fibrosis.
Survanta, a natural lung surfactant, showed eﬀectiveness in dispersing agglomerates of MWCNT to fine structures similar in
size to aerosolized one. At relevant low doses (0.002–0.2 μg/cm2 ), MWCNT exhibited a dose-dependent bio-eﬀect on the human
lung epithelial cells which is more pronounced in dispersed-MWCNT compared to non-dispersed form. Significantly elevated
levels of fibrogenic mediators, such as transforming growth factor-β1 and matrix metalloprotienases-9 were observed in the
dispersed-MWCNT treated lung epithelial cells. Based on previous in vivo studies showing that dispersed-MWCNT penetrated
the interstitium and caused rapid interstitial fibrosis, we evaluated the potential direct interaction between lung fibroblasts and
MWCNT. Direct stimulation of human lung fibroblast cell proliferation, collagen expression and fibroblast growth factor-2 were
observed which suggests novel mechanisms of MWCNT-induced lung fibrosis. Our results indicate that the dispersion status of
MWCNT determines their fibrogenic activity which is consistent with in vivo findings.

1. Introduction
Graphene-based multilayered nanofibers (less than 100 nm
in diameter), widely known as multiwalled carbon nanotubes (MWCNT), have wide commercial applications due
to their unique properties such as high tensile strength and
electrical conductivity. Their nanosized structure and low
density make them a potential airborne health hazard [1–
3]. However, the potential toxicity of fibrous MWCNT, especially the adverse eﬀects to human, is relatively unknown.
Research on this issue is urgently needed due to their rapidly
increasing use. Recent in vivo studies have shown that dispersed MWCNT induce interstitial lung fibrosis (only 1–
4 weeks post exposure) without causing persistent lung
inflammation [4, 5]. Previous studies by our group have
shown that dispersion of CNT is a key factor determining
its cellular interactions and bioactivities but the underlying
mechanisms of this unusual fibrosis are unknown [6–8].

We hypothesize that MWCNT induce fibrotic response by
directly stimulating lung fibroblasts to produce collagen
while stimulating lung epithelial cells to secrete profibrogenic
factors that promote the fibrotic process.
Interstitial lung fibrosis is considered an aberrant woundhealing response characterized by excessive extracellular
matrix (ECM) protein deposition (e.g., collagen) in the interstitial space [9]. Environmental and occupational exposure
to inhaled particulate matters is a leading cause of pulmonary
fibrosis resulting from dysregulated cytokine production
and repair mechanisms [10]. Transforming growth factorβ1 (TGF-β1) and matrix metalloproteinases (MMPs) are key
pulmonary mediators released by wounded or stressed lung
cells and their role in normal wound healing and pathologic
fibrosis is well established [10–12]. TGF-β1 is known to
induce lung fibrosis [11]. Members of MMP such as MMP2, 4, 7, and 9 are known mediators of fibrosis where they
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promote the recruitment of inflammatory and immune cells
to the site of injury [12–15], MMP-9 specifically breakdowns
extracellular matrix proteins. Under normal condition, these
mediators are expressed in low levels but are elevated during
cell injury and inflammation [16]. Although other fibrotic
mediators are involved in the fibrotic process, TGF-β1
and MMP-9 are major and reliable indicators of fibrotic
responses and were focused on in this study for potential
biomarkers of nanoparticle-induced lung fibrosis.
Recent in vivo data have shown that well-dispersed carbon nanotubes (CNTs) exhibit a more distal lung deposition
pattern and greater penetration into the alveolar interstitium,
terminal bronchioles, and proximal alveolar space as compared to their agglomerate form which deposits mainly in the
airspaces [6]. Deeper lung deposition of dispersed CNT may
directly induce unusual interstitial fibrosis in vivo but direct
evidence and detailed cellular mechanism are still lacking.
Therefore, lung epithelial cell and fibroblast cell were chosen
for this study.
The main objective of this study was to develop in vitro
models for fibrogenicity testing of CNT which may be used
to investigate the mechanisms of lung fibrosis induced by
CNT and other nanomaterials. The models could allow one
to measure the induction of collagen, TGF-β1, or MMP
by MWCNT-treated human lung cells which could serve as
potential biomarkers for MWCNT-induced fibrosis. Therefore, this study could have a predictive value in developing
simple and inexpensive in vitro assays for fibrogenesis. There
is an urgent need for this rapid and reliable in vitro method to
evaluate and predict the potential toxicity and fibrogenicity
of nanomaterials since their applications and incorporation
into commercial products is rapidly growing without a full
understanding of their possible health consequences upon
exposure.

2. Materials and Methods
2.1. MWCNT Source and Preparation. MWCNT used in
this study were provided by Mitsui & Company (MWNT7, lot no. 05072001K28) containing 0.41% metal impurity.
MWCNT was suspended in phosphate buﬀer saline (PBS)
at 0.1 mg/mL as nondispersed-MWCNT (ND-MWCNT).
The natural lung surfactant Survanta (Abbott Laboratories,
Columbus, OH) was used as a dispersion agent since it
exhibited no apparent cytotoxicity and had no masking
eﬀect on the bioactivity of CNT [17]. Survanta-dispersedMWCNT (SD-MWCNT) were prepared by addition of
150 μg/mL of Survanta. Before exposure, ND-MWCNT
and SD-MWCNT were lightly sonicated (Sonic Vibra Cell
Sonicator, Sonic & Material Inc., Newtown, CT, USA) with
the power, frequency, and amplitude settings of 130 W,
20 kHz, and 60% for 10 sec. As negative control particle,
dispersed ultrafine carbon black (UFCB), which does not
show any fibrogenic or cytotoxic bioactivity in vivo, was used
[18].
2.2. MWCNT Characterization and Size Measurements. Field
emission scanning electron microscopy (FESEM, model S4800; Hitachi, Tokyo, Japan) was used for size distribution
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analysis. ND- and SD-MWCNT were filtered onto a polycarbonate filter (VCTP02500 isopore membrane; Millipore,
Billerica, MA). After washing with purified water and drying,
the filter was cut into equal sections, mounted onto aluminum stubs with double-stick carbon tape and sputtercoated with gold/palladium. The deposited particles were
viewed under a FESEM at 400X and 30,000X magnifications.
Mean length and width size distributions (log normal) of
the particles in each sample were determined by analysis of
a minimum of 300 particle structures (dispersed or nondispersed form) (N). Count median length (CML) and count
median width (CMW) were determined for each group.
2.3. Cell Culture and Proliferation Assays. Human lung epithelial BEAS-2B cells were obtained from American Type
Culture Collection (ATCC, Manassas, VA) and were grown
in Dulbecco’s Modified Eagle Medium containing 5%
fetal bovine serum, 1% Penicillin/streptomycin and 1% LGlutamine (Sigma, St. Louis, MO). BEAS-2B cells were
derived from normal human bronchial epithelium and were
immortalized with a replication-defective SV40/adenovirus
12 hybrid. Human alveolar basal epithelial A549 cells (ATCC,
Manassas, VA) were grown in F-12 K Medium containing 5%
fetal bovine serum, 1% Penicillin/streptomycin and 1% LGlutamine (Sigma, St. Louis, MO). FibroblastCRL-1490 cells
(ATCC, Manassas, VA) were derived from normal human
lung fibroblasts and were cultured in Minimum Essential
Medium (MEM) containing 5% fetal bovine serum, 1%
Penicillin/streptomycin and 1% L-Glutamine (Sigma, St.
Louis, MO). For cell viability assay, cells were seeded in 24
well plates (2 × 104 cells/well) and treated with ND-MWCNT
or SD-MWCNT. Cell viability was measured after 48 h by
trypan blue assay using Countess automatic cell counter
(Invitrogen, Carlsbad, CA). Cell proliferation was analyzed
by using the 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5tetrazolio]-1,3-benzene disulfonate (WST-1) assay (Roche
Diagnostic, Mannheim, Germany) according to the manufacturer’s instructions. Briefly, cells (3 × 103 cells/well) were
cultured in 96-well plates and exposed to ND- or SDMWCNT. At 48 h after -exposure, cells were washed with PBS
and 100 μL of the WST-1 dye were added to each well and
allowed to incubate for 4 h. Absorbance was then measured at
450 nm using a plate reader (Molecular Device Spectra max
250, Sunnyvale, CA).
2.4. Western Blot Analysis and ELISA. Cells were cultured in
6-well tissue culture plates (1 × 105 cells/well) and exposed
to SD-MWCNT and various controls. At 48 h after exposure,
conditioned media were collected for ELISA. Cells were
washed twice with ice cold PBS. After a 10 min incubation
with lysis buﬀer (Cell Signaling Technology, Danvers, MA)
containing 1 mM phenylmethylsulfonyl fluoride (PMSF) and
a complete protease inhibitor cocktail (Roche, Mannheim,
Germany), cells were scraped and cell lysates were collected
for analysis of total protein content using bicinchoninic assay
(Pierce Biotechnology, Rockford, IL). Equal amounts of total
protein in each sample were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
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the resolved protein was transferred to a nitrocellulose membrane. The membrane was blocked for 1 h in TBST buﬀer
(25 mM Tris-HCl, pH 7.4, 125 mM NaCl, 0.05% Tween 20)
containing 5% nonfat dry milk and incubated overnight at
4◦ C with a primary antibody specific to TGF-β1 (Cell Signaling Technology, Danvers, MA), MMP-9 (R&D Systems,
Minneapolis, MN), fibroblast growth factor (FGF)-2 (Cell
Signaling, Danvers, MA), or collagen I (Fitzgerald, Concord,
MA). After primary antibody incubation, the membrane
was washed and incubated with horseradish peroxidaseconjugated secondary antibody for 1 h at room temperature.
The immune complexes were then detected by chemiluminescence (Supersignal West Pico, Pierce, Rockford, IL) and
quantified by densitometry using Adobe Photoshop image
analysis software (Adobe Software, San Jose, CA).
For analysis of secreted TGF-β1 and MMP-9, conditioned
media were collected and analyzed for the secreted proteins
using commercial ELISA kits from Invitrogen (Carlsbad,
CA) and EMD Chemicals (Gibbstown, UK), respectively.
Briefly, 100 μL of cell culture supernatant were added to
pre-antibody-coated 96-well plates for 2 h, after which
biotinylated peroxidase-conjugated secondary antibody was
added and the reaction was stopped by adding an acid
solution. The plate was then read for absorbance at 450 nm
(Molecular Device Spectra max 250, Sunnyvale, CA).
2.5. Sircol Soluble Collagen Assay. Sircol red collagen assay
kit (Biocolor Ltd., UK) was used to measure total soluble
collagen, according to the manufacturer’s protocol. Briefly,
fibroblasts (1 × 105 cells/well) were cultured in 6-well plates
and treated with MWCNT (0.02–0.06 μg/cm2 ) for 48 h. Cell
supernatants were collected and mixed with Sircol red dye
reagent for 30 min. A 200 μL aliquot of the mixed supernatant was transferred to a 96-well plate and analyzed for
absorbance at 555 nm (Molecular Device Spectra Max 250,
Sunnyvale, CA).
2.6. Statistical Analysis. ANOVA was performed to determine statistical significance between treatment and control
groups using Graph Pad Prism 5.1 (GraphPad Software Inc.,
La Jolla, CA) at a confidence level of P < 0.05∗ .

3. Results
3.1. Characterization and Size Distribution Analysis of NDand SD-MWCNT. To reduce agglomeration, the MWCNT
used in this study were dispersed in PBS containing
150 μg/mL of the natural lung surfactant, Survanta. This
concentration is physiologically relevant to the surfactant
concentration present in the lung lavage fluids and shown
to have no cytotoxic eﬀect and did not mask the surface
activity of particles. FESEM analysis of Survanta-dispersed
MWCNT shows that the surfactant is eﬀective in reducing
the MWCNT agglomerate size (Figure 1). Figures 1(a)–1(c)
show images of ND-MWCNT at increasing magnifications,
while Figures 1(d)–1(f) depict images of SD-MWCNT in
similar condition. Structure sizes were much smaller in
the SD-MWCNT preparation with the count median width
(CMW) and count median length (CML) of 78 nm and
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5.1 μm, respectively, versus ND-MWCNT with the CMW
and CML of 1.3 μm and 10.4 μm (Figure 2). Table 1 gives the
average mean diameter and length of 300 of SD-MWCNT
versus ND-MWCNT agglomerate structure measurements.
The mean width of SD-MWCNT structures was about 80 nm
which is comparable to the average diameter of aerosolized
MWCNT [19]. These results indicate that Survanta substantially improves the aqueous dispersion of MWCNT at
the concentration used. Furthermore, Survanta-dispersed
MWCNT remains physically stable with no appreciable
changes in particle size during storage at 4◦ C for months as
determined by electron microscopy. SD-MWCNT appeared
more dispersed and interacted more with the cells than NDMWCNT (Figure 3).
3.2. SD-MWCNT Induces More Cytotoxic Eﬀect in Lung
Epithelial Cells than ND-MWCNT. Cultured human lung
epithelial BEAS-2B cells were exposed to ND- or SDMWCNT and examined for MWCNT distribution and cytotoxicity. The studies were performed to optimize the doses
relevant to in vivo studies based on previously published
data [4, 8]. The doses of MWCNT used in this study
(0.002–0.6 μg/cm2 ) are physiologically relevant (equivalent
to dosimetry used in in vivo MWCNT exposure studies at
NIOSH) and derived from in vivo pulmonary exposure in
mice (10–80 μg/mouse with 500 cm2 estimated lung surface
area, which correspond to 0.02–0.16 μg/cm2 ) [4–6].
To assess the eﬀects of MWCNT on BEAS-2B cell
viability and proliferation, direct cell counting and WST-1
cell proliferation assays were performed. Since CNT interfere
with colorimetric dyes used in cytotoxicity assays, these
separate cytotoxicity assays were performed to avoid any
artificial results [20]. Figure 4(a) shows a dose-dependent
eﬀect of ND- and SD-MWCNT exposure on BEAS-2B cell
viability. Survanta only as a dispersion agent background
control and UFCB as negative particle control showed no
eﬀect on cell viability or proliferation. Both ND- and SDMWCNT caused a dose-dependent decrease in cell viability
at the concentration of 0.06 μg/cm2 or higher compared
to Survanta and UFCB (0.6 μg/cm2 ). However, the eﬀect
was significantly more pronounced in SD-MWCNT-treated
cells as compared to ND-MWCNT treated cells. ND- and
SD-MWCNT also showed a similar dose-dependent eﬀect
on cell proliferation as determined by WST-1 formazan dye
assay [21] (Figure 4(b)). Both forms of MWCNT inhibited
cell proliferation at doses >0.2 μg/cm2 with SD-MWCNT
being more potent, while Survanta alone and UFCB had
no significant eﬀect on both cell viability and proliferation
under the experimental condition. A similar result was also
observed in human lung adenocarcinoma A549 cells which
are slightly less sensitive to MWCNT than the BEAS-2B cells
(see Figures 1 and 2 in the Supplementary Material available online at doi:10.1155/2012/930931). Since dispersed
MWCNT are structurally similar to the aerosolized MWCNT
used during in vivo inhalation exposure, SD-MWCNTs were
selected for subsequent experiments in this study.
3.3. SD-MWCNT Induces TGF-β1 in Human Lung Epithelial
Cells. BEAS2B cells were treated with SD-MWCNT and
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Table 1: Size distribution analysis of agglomerates of ND & SD-MWNCT. The values in Table 1 are mean values computed by adding up a
collection of numbers and dividing by their count (300 fibre particles were measured in each group).
Length (Mean ± S.D.)
15.2 ± 1.0 μm
4.9 ± 0.54 μm

Nondispersed MWCNT agglomerate structures
Survanta-dispersed MWCNT agglomerate structures

50 μm
(a)

Width (mean ± S.D.)
7.7 ± 1.3 μm
0.082 ± 0.002 μm

50 μm
(d)

10 μm

10 μm
(e)

(b)

2 μm
(c)

2 μm
(f)

Figure 1: Particle characterization of nondispersed (ND) and Survanta-dispersed (SD) MWCNT. Field emission scanning electron
micrograph of nondispersed ((a)–(c)) and Survanta-dispersed MWCNT ((d)–(f)) at increasing magnifications (scales show 50 μm, 10 μm,
and 2 μm resp.). Large agglomerates of MWCNT are present in ND-MWCNT preparations (left panel) while small well-dispersed structures
are present in the SD-MWCNT sample (right panel).

Survanta only control for 48 h. TGF-β1 expression in cells
was measured by Western blot assay using cell lysates. Cell
supernatants were also collected and analyzed for secreted
TGF-β1 levels by ELISA. Figure 5(a) shows that MWCNTtreatment significantly increased the cellular expression of
TGF-β1 over vehicle control (Survanta) and UFCB levels.
A similar finding was observed with the secreted TGF-β1
with elevated levels in the SD-MWCNT-treated samples as
compared to nontreated and vehicle controls (Figure 5(b)).
3.4. SD-MWCNT Induces MMP-9 in Human Lung Epithelial
Cells. MMP-9 expression was also measured in MWCNTtreated BEAS-2B cells from the same experiment of
MWCNT-induced TGF-β1 by Western blotting. Figure 6(a)
shows that MWCNT were able to significantly induce MMP9 expression at the same concentration range that induces

TGF-β1 (e.g., 0.02–0.2 μg/cm2 ). Also levels of secreted MMP9 (Figure 6(b)) were significantly higher in conditioned
media from SD-MWCNT cells versus controls. SD-MWCNT
upregulated the expression of MMP-9 (Figure 6), suggesting
the involvement of this fibrogenic mediator in MWCNTinduced fibrosis. This study also suggests that MMP-9 and
TGF-β1 may serve as potential in vitro biomarkers for CNTinduced fibrogenesis.
3.5. Dose-Dependent Eﬀects of SD-MWCNT on Fibroblast Cell
Proliferation, Collagen Expression, and Cytotoxicity. Based on
in vivo data that pulmonary exposed dispersed MWCNT can
enter the lung interstitium, we addressed the potential direct
interaction and stimulating eﬀect of dispersed MWCNT
on lung fibroblasts. Human lung fibroblast CRL-1490 cells
were treated with various concentrations of SD-MWCNT
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CML = 10.4 μm, GSD = 2.3
ΔN/(NΔ log L) (μm−1 )

ΔN/(NΔ log L) (μm−1 )

2

5

1.5

1

0.5

0
0.1

CML = 5.1 μm, GSD = 2

1.5

1

0.5

0
1
10
100
ND-MWCNT length L (μm)

1000

0.1

1

10
100
SD-MWCNT length L (μm)

(a)

1000

(b)

2

3

CMW= 0.0783 μm, GSD = 1.46

CMW= 1.3 μm, GSD = 5.2
ΔN/(NΔ log W) (μm−1 )

ΔN/(NΔ log W) (μm−1 )

2.5
1.5

1

0.5

2
1.5
1
0.5

0
0.01

0.1

1

10

100

ND-MWCNT width W (μm)

0
0.01

0.1
1
10
SD-MWCNT width W (μm)

(c)

100

(d)

Figure 2: Size distribution analysis of agglomerates of nondispersed (ND) and Survanta-dispersed (SD) MWCNT. MWCNT were suspended
in PBS in the absence or presence of Survanta. The values are median values of distribution. Length and width distribution (log normal)
of ND-MWCNT are shown in (a) and (c), while length and width distribution (log normal) of SD-MWCNT are shown in (b) and (d). N:
MWCNT particle (agglomerates) number. Total counted particles are 300 in each case. CMW: count median width; CML: count median
length; GSD: geometric standard deviation.

and analyzed for cell proliferation and collagen production.
Figure 7(a) shows that SD-MWCNT exhibited a dual eﬀect
on cell proliferation, that is, stimulating eﬀect at low doses
(0.002–0.06 μg/cm2 ) and inhibitory eﬀect at high doses
(≥0.6 μg/cm2 ). Figure 7(b) shows that SD-MWCNT-induced
collagen I expression in lung fibroblasts compared to controls
as determined by Western blotting which was performed on
the basis of equal protein content and the results normalized
by β-actin content. Analysis of soluble collagen in the
treated cell culture medium by Sircol assay (Figure 7(c))
further showed that SD-MWCNTs were able to induce
collagen secretion from the treated cell, supporting the direct
fibrogenic eﬀect of SD-MWCNT on lung fibroblasts.
3.6. SD-MWCNT Induces FGF-2 Expression in CRL-1490
Cells. FGF-2 is a potent angiogenic factor and a key stimulant for fibroblast cell proliferation and TGF-β1-mediated
collagen induction [17]. To support the direct fibrogenic

eﬀect of SD-MWCNT on lung fibroblasts, we analyzed FGF-2
induction in MWCNT-treated fibroblasts. As expected, SDMWCNT induced FGF-2 expression in a dose-dependent
manner (Figure 8), consistent with its direct proliferative and
collagen-inducing eﬀects (Figure 7).

4. Discussion
The underlying cellular mechanism of the unusual fibrogenicity of MWCNT is largely unknown due in part to the
lack of well-characterized experimental models. In vivo models using animal provide valuable information of nanoparticle induced lung disorders such as fibrosis. Based on the
in vivo data, we investigated the mechanisms of CNTinduced lung fibrosis in vitro which allows more detailed
investigations such as dispersion status and dose eﬀect
of MWCNT, response of human cells to MWCNT, and
role of individual cell type. Success of the in vitro model
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100 μm
(a)

(b)

(c)

(d)

Figure 3: Light microscopy of nondispersed (ND) and Survanta-dispersed (SD) MWCNT-treated BEAS2B cells. BEAS-2B cells were either
left untreated (a) or treated with (b) 0.2 μg/cm2 of ND-MWCNT, (c) 0.2 μg/cm2 of SD-MWCNT, or (d) 0.6 μg/cm2 of SD-MWCNT for 48 h.
Large agglomerates (white arrow) were seen with ND-MWCNT (b), whereas much smaller structures of MWCNT were observed (CD). Note
the interaction of cells with MWCNT which is more apparent in SD-MWCNT-treated cells.
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Figure 4: Eﬀect of Survanta-dispersed MWCNT on cell viability and proliferation. BEAS-2B cells were exposed to 0.002–0.6 μg/cm2 of
nondispersed (ND-MWCNT) or Survanta-dispersed MWCNT (SD-MWCNT) for 48 h. Cell viability and proliferation were determined by
(a) trypan blue exclusion assay, and (b) WST-1 cell proliferation assay. Plots are mean ± S.D. from 4 independent experiments. ∗ P < 0.05
versus nontreated survanta control; # P < 0.05 versus ND-MWCNT treatment.

Journal of Nanomaterials

7

TGF β1

Relative fold change (TGF β1/β-actin)

β-actin
3
∗
∗
∗

2

1

Relative fold change (secreted TGF-β1)

2.5

0

∗

2

∗

∗

1.5

1

0.5

0
Surv

0.02

0.2
UFCB

0.06

SD-MWCNT

0

0.2
(μg/cm2 )

Surv

0.02

UFCB

(a)

0.06

SD-MWCNT

0.2
(μg/cm2 )

(b)

Figure 5: Eﬀect of MWCNT on TGF-β1 expression. BEAS-2B cells were exposed to 0.02–0.2 μg/cm2 of SD-MWCNT for 48 h. Endogenous
TGF-β1 levels in cell lysates were measured by Western blotting and compared with nontreated Survanta only control. (a) TGF-β1 levels
(45–50 kD) were quantified by gel densitometry. (b) Secreted TGF-β1 levels in the treated cell supernatants were measured by ELISA. Plots
are mean ± S.D. from 3 independent experiments. ∗ P < 0.05 versus nontreated control.
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Figure 6: Eﬀect of MWCNT on MMP-9 expression. BEAS-2B cells were exposed to 0.02–0.2 μg/cm2 of SD-MWCNT for 48 h and the levels
of both cellular and secreted MMP-9 were detected. (a) MMP-9 (92 kD) was measured by Western blotting and compared with no treatment
(0) and Survanta only controls (Surv). MMP-9 expression levels were quantified by gel densitometry. (b) Secreted MMP-9 in the supernatant
of MWCNT-treated BEAS-2B cells detected by ELISA. Plots are mean ± S.D. from 4 independent experiments ∗ P < 0.05 versus Survanta
only control.
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Figure 7: Eﬀects of MWCNT on cell proliferation and collagen expression in human lung fibroblasts. CRL-1490 cells were left untreated (0)
or treated with the indicated concentrations of SD-MWCNT or Survanta only (Surv) and analyzed for (a) cell proliferation by WST-1 assay,
(b) collagen I expression by Western blotting, and (c) soluble collagen content by Sircol assay. Plots are mean ± S.D. from 4 independent
experiments ∗ P < 0.05 versus nontreated control.

development will also benefit nanotoxicology research since
it is such a simple and easy tool for nanorisk evaluation as
compared to the use of animal models which is time consuming, laborious, and impractical for analyzing a wide
variety and rapidly increasing number of nanomaterials.
CNT are hydrophobic and tend to form agglomerates in
aqueous solutions and biological fluids. In order to mimic
physiological condition that inhaled MWCNT will contact
alveolar surface which is covered by lung surfactant, a natural
lung surfactant, Survanta, was used as a dispersing agent in
this study. Survanta as a dispersing agent provides certain
advantages; it is biocompatible, commercially available, and
easy to prepare with no apparent cytotoxicity when used
at the indicated doses [8]. FESEM analysis of Survantadispersed MWCNT showed that Survanta is eﬀective in

reducing the MWCNT agglomerate size (Figure 1) which is
similar to aerosolized MWCNT. This observation supports
the use of Survanta-dispersed MWCNT to mimic airborne
workplace exposure since a single MWCNT fiber is a very
unlikely existence. Size distribution analysis showed good
uniformity of dispersion of the MWCNT (Figure 2). The
more potent bioeﬀect of SD-MWCNT could be due to
an increase in the number of particles per unit mass and
surface area which increases their interaction with cells as
demonstrated in Figure 3.
Cytotoxicity studies of the MWCNT were performed to
optimize the doses relevant to in vivo studies [4]. The doses
of MWCNT used in this study (0.02–0.6 μg/cm2 ) are derived
from in vivo pulmonary exposure doses (10–80 μg/mouse)
of MWCNTs that induce lung fibrosis in animals. This
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Figure 8: Induction of FGF-2 by MWCNT in lung fibroblasts.
Fibroblast CRL-1490 cells were exposed to the indicated concentrations of SD-MWCNT or Survanta for 48 h and analyzed for
FGF-2 expression by Western blotting. FGF-2 expression levels were
quantified using gel densitometry. Plots are mean ± S.D. from 4
independent experiments. ∗ P < 0.05 versus Survanta only control.

dose range of MWCNT was found to significantly induce
toxicity in lung epithelial BEAS-2B cells (Figures 4–6). A
similar result was also observed in lung epithelial A549 cells,
although the response in this cell line was less pronounced
than in the BEAS-2B cell line. The results of the cytotoxicity
studies also suggest that the dispersed form of MWCNT is
more toxic to BEAS-2B cells than the nondispersed form.
The variable response of BEAS-2B to ND- and SD-MWCNT
exposure observed in the present study was likely due to
the diﬀerence in agglomerate size or contact surface area
with the cells. Although CNT have been reported to cause
artifacts in the WST-1 assay [17, 21], the doses of MWCNT
used in this study were orders of magnitude lower than
those reported to adsorb the formazan dye used in this assay.
Furthermore, direct cell counting experiments gave similar
results. These data are consistent with nanoparticle toxicity
studies in nonlung cell lines using other dispersing agents
[22, 23]. The variable response to low-dose ND- and SDMWCNT is likely due to the diﬀerence in particle size and
contact surface area with the cells.
Fibrosis is a disease of multiple cellular origin involving
complex and interrelated signaling pathways. Lung alveolar
microphages (AMs) and epithelial cells play an important
role in the regulation of fibrosis by producing cytokines
and growth factors along with fibroblasts [10, 22, 23]. For
example, TGF-β1 is one of the most potent fibrogenic

mediators [11, 24] and is found to be elevated in mouse lungs
after pulmonary exposure to CNT [18, 25, 26]. Once secreted
from stimulated or injured AM or epithelial cells into the
ECM, TGF-β1 can stimulate fibroblasts to produce collagen
that contributes to epithelial-mesenchymal transition [27].
Unlike microsized particles, well-dispersed CNT might be
selectively engulfed by AM which is being investigated in
our laboratory. In this study, the bioeﬀects of MWCNT in
epithelial cells and fibroblasts are part of a series of nanotoxicology studies using diﬀerent individual lung cells. Several
well-accepted fibrogenic mediators were first checked. SDMWCNT induced TGF-β1 in BEAS-2B cell, as well as an
elevated level of secreted TGF-β1 in cell culture supernatants
of the same MWCNT-treated cells (Figure 5(b)). MMP9 is a key regulator of pulmonary fibrosis and is known
to be involved in the pathogenesis of lung fibrosis mainly
through its ability to regulate the ECM [12]. An elevated
level of MMPs in the ECM is generally indicative of a fibrotic
or reparative process. MWCNT upregulated the expression
of MMP-9 (Figure 6), suggesting the involvement of this
fibrogenic mediator in MWCNT-induced lung fibrosis. This
study also suggests that MMP-9 and TGF-β1 may serve as
potential early biomarkers for CNT-induced fibrosis.
Pulmonary inhaled particles are normally excluded from
the interstitial connective tissue by the protective epithelial
barrier. However, recent studies have shown that welldispersed CNT can enter the interstitial space [4, 6, 27].
Therefore, interstitial lung fibroblast was specifically chosen
for our in vitro studies to determine its direct interaction with
the dispersed MWCNT. SD-MWCNT enhanced the proliferation of lung fibroblasts at lower doses (0.002–0.06 μg/cm2 )
but were cytotoxic at doses >0.6 μg/cm2 (Figure 7(a)). The
stimulating eﬀect of SD-MWCNT on lung fibroblasts may
contribute to rapid interstitial fibrosis induced by dispersed
MWCNT. SD-MWCNT also stimulated collagen I expression
in cultured lung fibroblasts (Figure 7(b)) and secreted
soluble collagen from the cells (Figure 7(c)) as compared
to controls. This finding is in good agreement with a
recent in vivo study showing a dose- and time-dependent
eﬀect of SD-MWCNT exposure on lung collagen content in
mice [7]. Figure 7(b) also showed that MWCNT-induced
collagen I expression was reduced at the concentration of
0.2 μg/cm2 , which is likely due to a decrease in fibroblast
cell viability (Figure 7(a)). The aforementioned data suggest
that direct stimulation of both fibroblast cell proliferation
and collagen production may be an explanation for the
unusual rapid interstitial fibrosis induced by dispersed
MWCNT. Collagen, a hallmark of fibrosis, could serve as a
biomarker for fibrogenicity testing of nanomaterials using
this cultured fibroblast model. Our study also showed that
MWCNT induced FGF-2 (Figure 8), which is known to
stimulate fibroblast cell growth. The precise role of this and
other growth factors and cytokines in MWCNT-induced
lung fibrosis are unclear and are being investigated in our
laboratory.
Currently, there is a great need for the development of
rapid and reliable methods for toxicity and fibrogenicity testing of nanomaterials due to their growing applications and
incorporation into commercial products at a time when there
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is a limited understanding of their possible health eﬀects.
Traditional fibrosis studies in animals, while providing useful
information about the fibrogenicity of nanomaterials, are
time consuming, laborious, and impractical for analysis of
the vast variety and rapidly increasing number of nanomaterials. The present study describes an alternative in vitro
method for fibrogenicity testing of nanomaterials based on
the use of relevant human lung cell models. The ability of
CNT to induce fibrogenic factors in lung cells and stimulate
fibroblast cell growth and collagen production was used as
indicators of lung fibrogenesis. Consistent with previous in
vivo data by our group and others, the results of this study
demonstrated the potential usefulness of the in vitro cell
models as rapid screening tools for fibrogenicity testing of
other nanomaterials. The cell models may also be used to aid
detailed mechanistic investigations of the fibrogenic process.
In conclusion, the results of this study indicate that
Survanta was eﬀective in dispersing MWCNT agglomerates
in suspension into nanosized structures which are similar in
size as their aerosolized form. MWCNT exhibited a dosedependent cellular eﬀect on human lung epithelial cells
which is more pronounced in a dispersed form as compared
to nondispersed form. SD-MWCNT significantly elevated
the levels of fibrogenic mediators such as TGF-β1 and MMP9, and stimulated fibroblast proliferation and upregulated its
expression of collagen I and secretion of FGF-2. This study
describes an alternative in vitro method for fibrogenicity
testing of MWCNT which could be useful in mechanistic
investigations of lung fibrosis induced by CNT and other
nanomaterials.
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